We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, EMA Form Pharmacovigilance ‘Cluster’ to Enhance Drug Safety
FDA, EMA Form Pharmacovigilance ‘Cluster’ to Enhance Drug Safety
The U.S. Food and Drug Administration and European Medicines Agency have launched a new information-sharing initiative aimed at speeding international responses to drug safety problems.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor